Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malignant Melanoma

Free Subscription Articles published in J Immunol Retrieve available abstracts of 22 articles: HTML format

Single Articles

December 2023
1. PEIL J, Vossen C, Bock F, Clahsen T, et al
   Combined Osteopontin Blockade and Type 2 Classical Dendritic Cell Vaccination as Effective Synergetic Therapy for Conjunctival Melanoma.
   J Immunol. 2023 Dec 15:ji2300063. doi: 10.4049/jimmunol.2300063.
   PubMed     Abstract available
   
   
   
2. SINGH S, Xiao Z, Bavisi K, Roszik J, et al
   Corrections: IL-1alpha mediates innate and acquired resistance to immunotherapy in melanoma.
   J Immunol. 2023 Dec 13:ji2300689. doi: 10.4049/jimmunol.2300689.
   PubMed     Abstract available
   
   
   July 2023
3. THOMPSON B, Strange A, Amato CM, Hester-McCullough J, et al
   CD4 Phenotypes Are Associated with Reduced Expansion of Tumor-Infiltrating Lymphocytes in Melanoma Patients Treated with Adoptive Cell Therapy.
   J Immunol. 2023 Jul 19:ji2300250. doi: 10.4049/jimmunol.2300250.
   PubMed     Abstract available
   
   
   March 2023
4. ALAM MM, Gower T, Jiang M, Oppenheim JJ, et al
   A Therapeutic Vaccine in Combination with Cyclic GMP-AMP Cures More Differentiated Melanomas in Mice.
   J Immunol. 2023 Mar 22:ji2200371. doi: 10.4049/jimmunol.2200371.
   PubMed     Abstract available
   
   
   December 2022
5. MIYAMOTO M, Himeda T, Ishihara K, Okuwa T, et al
   Theilovirus 3C Protease Cleaves the C-Terminal Domain of the Innate Immune RNA Sensor, Melanoma Differentiation-Associated Gene 5, and Impairs Double-Stranded RNA-Mediated IFN Response.
   J Immunol. 2022 Dec 14:ji2200565. doi: 10.4049/jimmunol.2200565.
   PubMed     Abstract available
   
   
   September 2022
6. LI P, Chen X, Ping Y, Qin G, et al
   Clinical Correlation of Function and TCR vbeta Diversity of MAGE-C2-Specific CD8(+) T Cell Response in Esophageal Cancer.
   J Immunol. 2022;209:1039-1047.
   PubMed     Abstract available
   
   
   July 2022
7. PAN W, Scherlinger M, Yoshida N, Tsokos MG, et al
   PPP2R2D Suppresses Effector T Cell Exhaustion and Regulatory T Cell Expansion and Inhibits Tumor Growth in Melanoma.
   J Immunol. 2022 Jul 13. pii: jimmunol.2200041. doi: 10.4049/jimmunol.2200041.
   PubMed     Abstract available
   
   
   
8. VOILLET V, Berger TR, McKenna KM, Paulson KG, et al
   An In Vivo Model of Human Macrophages in Metastatic Melanoma.
   J Immunol. 2022 Jul 11. pii: jimmunol.2101109. doi: 10.4049/jimmunol.2101109.
   PubMed     Abstract available
   
   
   April 2022
9. BORDEN ES, Ghafoor S, Buetow KH, LaFleur BJ, et al
   NeoScore Integrates Characteristics of the Neoantigen:MHC Class I Interaction and Expression to Accurately Prioritize Immunogenic Neoantigens.
   J Immunol. 2022;208:1813-1827.
   PubMed     Abstract available
   
   
   January 2022
10. SILK JD, Abbott RJM, Adams KJ, Bennett AD, et al
    Engineering Cancer Antigen-Specific T Cells to Overcome the Immunosuppressive Effects of TGF-beta.
    J Immunol. 2022;208:169-180.
    PubMed     Abstract available
    
    
    November 2021
11. HINKLE L, Liu Y, Meng C, Chen Z, et al
    The Sympathetic Nervous System Modulates Cancer Vaccine Activity through Monocyte-Derived Cells.
    J Immunol. 2021 Nov 12. pii: jimmunol.2100719. doi: 10.4049/jimmunol.2100719.
    PubMed     Abstract available
    
    
    September 2021
12. LI Z, Gao Y, He C, Wei H, et al
    Purinergic Receptor P2Y6 Is a Negative Regulator of NK Cell Maturation and Function.
    J Immunol. 2021;207:1555-1565.
    PubMed     Abstract available
    
    
    
13. OROZCO RC, Marquardt K, Mowen K, Sherman LA, et al
    Proautoimmune Allele of Tyrosine Phosphatase, PTPN22, Enhances Tumor Immunity.
    J Immunol. 2021;207:1662-1671.
    PubMed     Abstract available
    
    
    
14. ISLAM A, Pishesha N, Harmand TJ, Heston H, et al
    Converting an Anti-Mouse CD4 Monoclonal Antibody into an scFv Positron Emission Tomography Imaging Agent for Longitudinal Monitoring of CD4(+) T Cells.
    J Immunol. 2021;207:1468-1477.
    PubMed     Abstract available
    
    
    July 2021
15. CARLSON PM, Mohan M, Patel RB, Birstler J, et al
    Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.
    J Immunol. 2021;207:720-734.
    PubMed     Abstract available
    
    
    
16. BANERJEE A, Li D, Guo Y, Mahgoub B, et al
    Retargeting IL-2 Signaling to NKG2D-Expressing Tumor-Infiltrating Leukocytes Improves Adoptive Transfer Immunotherapy.
    J Immunol. 2021;207:333-343.
    PubMed     Abstract available
    
    
    April 2021
17. CHEN CW, Bennion KB, Swift DA, Morrow KN, et al
    Tumor-Specific T Cells Exacerbate Mortality and Immune Dysregulation during Sepsis.
    J Immunol. 2021 Apr 28. pii: jimmunol.2000865. doi: 10.4049/jimmunol.2000865.
    PubMed     Abstract available
    
    
    March 2021
18. SINGH S, Xiao Z, Bavisi K, Roszik J, et al
    IL-1alpha Mediates Innate and Acquired Resistance to Immunotherapy in Melanoma.
    J Immunol. 2021 Mar 15. pii: jimmunol.2000523. doi: 10.4049/jimmunol.2000523.
    PubMed     Abstract available
    
    
    January 2021
19. O'CONNELL P, Hyslop S, Blake MK, Godbehere S, et al
    SLAMF7 Signaling Reprograms T Cells toward Exhaustion in the Tumor Microenvironment.
    J Immunol. 2021;206:193-205.
    PubMed     Abstract available
    
    
    October 2020
20. OBA T, Hoki T, Yamauchi T, Keler T, et al
    A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells.
    J Immunol. 2020;205:1867-1877.
    PubMed     Abstract available
    
    
    July 2020
21. TUCKER CG, Mitchell JS, Martinov T, Burbach BJ, et al
    Adoptive T Cell Therapy with IL-12-Preconditioned Low-Avidity T Cells Prevents Exhaustion and Results in Enhanced T Cell Activation, Enhanced Tumor Clearance, and Decreased Risk for Autoimmunity.
    J Immunol. 2020 Jul 31. pii: jimmunol.2000007. doi: 10.4049/jimmunol.2000007.
    PubMed     Abstract available
    
    
    April 2020
22. WILSKI NA, Stotesbury C, Del Casale C, Montoya B, et al
    STING Sensing of Murine Cytomegalovirus Alters the Tumor Microenvironment to Promote Antitumor Immunity.
    J Immunol. 2020 Apr 13. pii: jimmunol.1901136. doi: 10.4049/jimmunol.1901136.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.